Peripheral hearing in Parkinson's disease: a systematic review

Carregando...
Imagem de Miniatura
Citações na Scopus
2
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
TAYLOR & FRANCIS LTD
Citação
INTERNATIONAL JOURNAL OF AUDIOLOGY, v.62, n.9, p.805-813, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objective To investigate the implications of Parkinson's disease (PD) in the peripheral auditory system, a systematic survey of the scientific literature was conducted. Design Systematic review. Study sample An electronic search of the non-gray literature in the last decade was conducted using the digital databases MEDLINE (R) (PubMed interface), LILACS (R) (Virtual Health Library), Web of Science (R) (CAPES publications portal), and SciELO (R). Studies addressing peripheral auditory function as part of the range of nonmotor PD symptoms were selected for analysis. Results Pure tone audiometry data suggested that sensorineural hearing loss was more severe in the PD population than in the control groups. The effects of PD on cochlear function were evidenced by a decrease in the levels of otoacoustic emissions. Conclusions Sensorineural hearing loss and cochlear impairment are more severe in the PD population than in the control groups. Additional studies are recommended to further understand the characteristics of the peripheral auditory system in PD patients, which constitutes an emerging subject in the scientific literature.
Palavras-chave
Neurodegenerative disease, hearing loss, early diagnosis, systematic review
Referências
  1. Akil O, 2008, JARO-J ASSOC RES OTO, V9, P452, DOI 10.1007/s10162-008-0134-y
  2. [Anonymous], 2021, BMJ
  3. Ayala A, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00551
  4. Barone P, 2010, EUR J NEUROL, V17, P364, DOI 10.1111/j.1468-1331.2009.02900.x
  5. Belkhiria C, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00097
  6. Bott A, 2021, INT J AUDIOL, V60, P30, DOI 10.1080/14992027.2021.1915506
  7. Cardin V, 2020, INT J AUDIOL, V59, P674, DOI 10.1080/14992027.2020.1734675
  8. Castiglione A, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01279
  9. Cerroni R, 2020, MOVEMENT DISORD, V35, P1283, DOI 10.1002/mds.28131
  10. Collier TJ, 2017, MOVEMENT DISORD, V32, P983, DOI 10.1002/mds.27037
  11. Cury RG, 2014, NEUROLOGY, V83, P1403, DOI 10.1212/WNL.0000000000000887
  12. De Groote E, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00689
  13. De Keyser K, 2019, J SPEECH LANG HEAR R, V62, P4564, DOI 10.1044/2019_JSLHR-H-19-0097
  14. Di Mauro R., 2017, J ALZHEIMERS DIS PAR, V7, P396, DOI [DOI 10.4172/2161-0460.1000396, 10.4172/2161-0460.1000396]
  15. Dorsey ER, 2007, NEUROLOGY, V68, P384, DOI 10.1212/01.wnl.0000247740.47667.03
  16. Eckert MA, 2019, TRENDS HEAR, V23, DOI 10.1177/2331216519857267
  17. Eversfield CL, 2019, PSYCHOL MED, V49, P2342, DOI 10.1017/S0033291718003161
  18. EYBALIN M, 1993, NEUROSCIENCE, V54, P133, DOI 10.1016/0306-4522(93)90389-W
  19. Folmer RL, 2017, BIOMED RES INT-UK, V2017, DOI 10.1155/2017/2618587
  20. Garrett AR, 2011, AUDIOL NEURO-OTOL, V16, P145, DOI 10.1159/000316674
  21. Goldman JG, 2014, CURR OPIN NEUROL, V27, P434, DOI 10.1097/WCO.0000000000000112
  22. Guinan J.J., 1996, COCHLEA, P435, DOI 10.1007/978-1-4612-0757-3_8
  23. Guinan JJ, 2018, HEARING RES, V362, P38, DOI 10.1016/j.heares.2017.12.012
  24. Hoff M, 2020, INT J AUDIOL, V59, P682, DOI 10.1080/14992027.2020.1731766
  25. Hussein M, 2019, EGYPT J OTOLARYNGOL, V35, P313, DOI 10.4103/ejo.ejo_18_18
  26. Jafari Z, 2020, MOVEMENT DISORD, V35, P537, DOI 10.1002/mds.28000
  27. Kalia LV, 2015, LANCET, V386, P896, DOI 10.1016/S0140-6736(14)61393-3
  28. Kemp DT, 2002, BRIT MED BULL, V63, P223, DOI 10.1093/bmb/63.1.223
  29. König M, 2019, ACS CHEM NEUROSCI, V10, P1915, DOI 10.1021/acschemneuro.8b00274
  30. Lai SW, 2014, EUR J NEUROL, V21, P752, DOI 10.1111/ene.12378
  31. Li TB, 2020, NEUROSCI BULL, V36, P183, DOI 10.1007/s12264-019-00433-1
  32. Lin CH, 2017, J NEUROL NEUROSUR PS, V88, P818, DOI 10.1136/jnnp-2016-314857
  33. Liu J, 2020, TOP GERIATR REHABIL, V36, P194, DOI 10.1097/TGR.0000000000000280
  34. Lopes MD, 2019, CODAS, V31, DOI 10.1590/2317-1782/20182018249
  35. Lopes Marcia da Silva, 2018, Rev. CEFAC, V20, P573, DOI 10.1590/1982-021620182052418
  36. Mullen R., 2007, ASHA LEADER, V12, P8, DOI [10.1044/leader.FTR4.12032007.8, DOI 10.1044/LEADER.FTR4.12032007.8]
  37. Musiek FE, 2017, J AM ACAD AUDIOL, V28, P655, DOI 10.3766/jaaa.16061
  38. Ortmann AJ, 2016, EAR HEARING, V37, P603, DOI 10.1097/AUD.0000000000000319
  39. Park A, 2009, J NEUROL, V256, pS293, DOI 10.1007/s00415-009-5240-1
  40. Park SN, 2011, NEUROSCI RES, V71, P303, DOI 10.1016/j.neures.2011.07.1835
  41. Patel RA, 2015, J PARKINSONISM RESTL, V5, P19, DOI 10.2147/JPRLS.S62065
  42. Pisani V, 2015, PARKINSONISM RELAT D, V21, P987, DOI 10.1016/j.parkreldis.2015.06.007
  43. Puel JL, 1995, PROG NEUROBIOL, V47, P449, DOI 10.1016/0301-0082(95)00028-3
  44. PUJOL R, 1994, BRIT J AUDIOL, V28, P185, DOI 10.3109/03005369409086567
  45. Rabelo Maysa Bastos, 2018, Rev. CEFAC, V20, P135, DOI 10.1590/1982-0216201820213117
  46. Scarpa A, 2020, PARKINSONISM RELAT D, V71, P51, DOI 10.1016/j.parkreldis.2020.01.018
  47. Shalash AS, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00055
  48. Shetty K, 2019, J MOV DISORD, V12, P84, DOI 10.14802/jmd.18048
  49. Sisto R, 2020, BRAIN COMMUN, V2, DOI 10.1093/braincomms/fcaa144
  50. Uchida Y, 2008, EAR HEARING, V29, P176, DOI 10.1097/AUD.0b013e3181634eb8
  51. Uluyol S, 2016, TURK J GERIATR, V19, P228
  52. Vitale C, 2012, MOVEMENT DISORD, V27, P1530, DOI 10.1002/mds.25149
  53. Wersinger E, 2011, HEARING RES, V279, P1, DOI 10.1016/j.heares.2010.12.018
  54. World Health Organization, 2011, GLOBAL HLTH AGING
  55. Yylmaz S, 2009, EUR ARCH OTO-RHINO-L, V266, P669, DOI 10.1007/s00405-009-0933-8
  56. Zeigelboim Bianca Simone, 2011, Arquivos Int. Otorrinolaringol., V15, P189, DOI 10.1590/S1809-48722011000200011